Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.

Biotechnology

Peptinovo Biopharma

Peptinovo Biopharma's headquarters in Ann Arbor, MI, United States

Steve Tokarz

Bill Elliott

Ren Homan

Peptinovo Biopharma's Leadership Team includes Steve Tokarz and 2 others.

About

People (3)

Bill Elliott

Ren Homan

Steve Tokarz

Jobs